Annovis Bio, Inc. (ANVS)
Largest Insider Buys in Sector
ANVS Stock Price History Chart
ANVS Stock Performance
About Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to …
Insider Activity of Annovis Bio, Inc.
Over the last 12 months, insiders at Annovis Bio, Inc. have bought $0 and sold $0 worth of Annovis Bio, Inc. stock.
On average, over the past 5 years, insiders at Annovis Bio, Inc. have bought $686,010 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $137,000 was made by White Mark K. (director) on 2021‑10‑12.
List of Insider Buy and Sell Transactions, Annovis Bio, Inc.
| 2021-10-12 | director | 5,000 0.148% | $27.40 | $137,000 | -49.71% | |||
| 2021-10-11 | PRESIDENT AND CEO | 18,000 0.5368% | $27.61 | $496,980 | -49.37% | |||
| 2021-10-11 | director | 181 0.0054% | $27.66 | $5,006 | -49.37% | |||
| 2021-08-19 | director | 500 0.0203% | $37.61 | $18,805 | -59.74% | |||
| 2020-02-03 | Chief Financial Officer | 19,500 0.1506% | $7.15 | $139,428 | -30.90% | |||
| 2020-01-31 | President and CEO | 1,600 0.0104% | $6.00 | $9,600 | -23.31% | |||
| 2020-01-31 | 33,333 0.216% | $6.00 | $199,998 | -23.31% | ||||
| 2020-01-31 | Chief Financial Officer | 33,333 0.216% | $6.00 | $199,998 | -23.31% | |||
| 2020-01-31 | director | 25,000 0.162% | $6.00 | $150,000 | -23.31% | |||
| 2020-01-31 | director | 1,734 0.0112% | $6.00 | $10,404 | -23.31% | |||
| 2020-01-31 | director | 800 0.0052% | $6.00 | $4,800 | -23.31% |
Insider Historical Profitability
| Maccecchini Maria-Luisa | PRESIDENT AND CEO | 976775 7.0795% | $5.01 | 2 | 0 | <0.0001% |
| White Mark K. | director | 56177 0.4072% | $5.01 | 2 | 0 | <0.0001% |
| McGroarty Jeffrey Brian | Chief Financial Officer | 52833 0.3829% | $5.01 | 2 | 0 | |
| Hoffman Michael B | 47619 0.3451% | $5.01 | 1 | 0 | ||
| Whelan, Jr. Robert M. | director | 25000 0.1812% | $5.01 | 1 | 0 |